Recent Advancements in the Atopic Dermatitis Mechanism
Open accessThe DOI matches its Crossref record; 159 of the 159 references it cites were found in a registry or an index.
Abstract
Atopic dermatitis (AD) is a recurrent, chronic, inflammatory, itchy skin disorder that affects up to 20% of the pediatric population and 10% of the adult population worldwide. Onset typically occurs early in life, and although cardinal disease features are similar across all ages, different age groups and ethnicities present distinct clinical characteristics. The disease imposes a significant burden in all health-related quality of life domains, both in children and adults, and a substantial economic cost both at individual and national levels. The pathophysiology of AD includes a complex and multifaceted interplay between the impaired dysfunctional epidermal barrier, genetic predisposition, and environmental contributors, such as chemical and/or biological pollutants and allergens, in the context of dysregulated TH2 and TH17 skewed immune response. Regarding the genetic component, the loss of function mutations encoding structural proteins such as filaggrin, a fundamental epidermal protein, and the more recently identified variations in the epidermal differentiation complex are well-established determinants resulting in an impaired skin barrier in AD. More recently, epigenetic factors have facilitated AD development, including the dysbiotic skin microbiome and the effect of the external exposome, combined with dietary disorders. Notably, the interleukin (IL)-31 network, comprising several cell types, including macrophages, basophils, and the generated cytokines involved in the pathogenesis of itch in AD, has recently been explored. Unraveling the specific AD endotypes, highlighting the implicated molecular pathogenetic mechanisms of clinically relevant AD phenotypes, has emerged as a crucial step toward targeted therapies for personalized treatment in AD patients. This review aims to present state-of-the-art knowledge regarding the multifactorial and interactive pathophysiological mechanisms in AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Tobacco smoke, whether through active or passive exposure, delivers benzene to the skin, which interferes with the inhibitory ability of TREG cells to secrete IL-10 and exert anti-inflammatory effects, which results in a higher prevalence of AD in children with relatives who smoke.”
From Update on the pathogenesis of atopic dermatitis. (2024) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The number of M2 macrophages expressing IL-31, CD68+ macrophages, and basophils in biopsies of skin affected by AD is positively related to TSLP and periostin expression in the epidermis of affected skin in patients with AD and also to disease severity.61”
From Update on the pathogenesis of atopic dermatitis. (2024) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, IL-4 and IL-13 constitute the main cytokines associated with the pathogenesis of early AD, as in addition to promoting type 2 inflammatory responses and recruiting eosinophils to the skin, they damage the epidermal barrier by suppressing the expression of structural proteins such as filaggrin, loricrin, and lipids, while concomitantly increasing collagen deposition in the dermis, which”
From Update on the pathogenesis of atopic dermatitis. (2024) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“IL-18 acts on receptors (IL-18Rα) overexpressed on eosinophils in patients with AD and the histamine released by mast cells and basophils increases the expression of IL-18 on eosinophils by binding histamine with H2R and H4R, suggesting a relevant function of IL-18 and histamine in eosinophilic inflammation in AD.61”
From Update on the pathogenesis of atopic dermatitis. (2024) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Elevated serum levels of IL-21 are observed in patients with AD, primarily produced by Th17 cells, which is associated with greater AD severity when compared to healthy controls so IL-21 directly promotes type 2 inflammation and suppresses Th1 responses by suppressing INFγ production.61”
From Update on the pathogenesis of atopic dermatitis. (2024) · cites this paper as [61]
Experimental — accuracy not yet measured
17 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wild, C. P. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0456 · Cited by 2,562 · cited 1×
“[108], highlighting the bidirectional interaction of the external environment and human health and disease, complementing the gene—environmental associations in the pathogenesis of allergic diseases.”
BackgroundTwo Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Simpson, E. L., Bieber, T., Guttman-Yassky, E., Beck, L. A., Blauvelt, A., Cork, M. J., Silverberg, J. I., Deleuran, M., Kataoka, Y., Lacour, J.-P., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1610020 · Cited by 2,110 · cited 1×
“Subsequently, new therapeutic targets aiming at inhibiting IL-4R using monoclonal antibodies and JAK inhibitors are developed [137,138], while the inhibition of IL-13 using monoclonal antibodies attenuates the itch in AD [18,19].”
BackgroundLangan, S. M., Irvine, A. D., & Weidinger, S. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31286-1 · Cited by 1,852
Weidinger, S., Beck, L. A., Bieber, T., Kabashima, K., & Irvine, A. D. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0001-z · Cited by 1,549
Sensory Neurons Co-opt Classical Immune Signaling Pathways to Mediate Chronic Itch
Oetjen, L. K., Mack, M. R., Feng, J., Whelan, T. M., Niu, H., Guo, C. J., Chen, S., Trier, A. M., Xu, A. Z., Tripathi, S. V., et al. (2017) · Cell · doi:10.1016/j.cell.2017.08.006 · Cited by 1,092 · cited 3×
“…IL-4, IL-13, and IL-31, act through the TRP channel ankyrin transmembrane protein 1 (TRPA1) and the transient receptor potential (TRP) channel vallinoid 1 (TRPV1) by activating the calcium influx in the sensory fibers [134], while TSLP acts directly on the sensory nerves by binding to its receptor.”
BackgroundAkdis, C. A. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00538-7 · Cited by 981 · cited 1×
“Microbiome dysbiosis in AD impairs immune responses and, in response to the ex-posome effects, contributes to the “leaking epithelium”, the subepithelial translocation of dysbiotic microbiota and opportunistic pathogens [82].”
BackgroundStänder, S. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2023911 · Cited by 756
Guttman-Yassky, E., Bissonnette, R., Ungar, B., Suárez-Fariñas, M., Ardeleanu, M., Esaki, H., Suprun, M., Estrada, Y., Xu, H., Peng, X., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.08.022 · Cited by 697 · cited 1×
“Importantly, the data indicate a restorative effect of dupilumab in AD by progressively ameliorating systemic and cutaneous abnormalities [63].”
BackgroundWollenberg, A., Blauvelt, A., Guttman‐Yassky, E., Worm, M., Lynde, C., Lacour, J. ‐., Spelman, L., Katoh, N., Saeki, H., Poulin, Y., et al. (2021) · British Journal of Dermatology · doi:10.1111/bjd.19574 · Cited by 638 · cited 2×
“Subsequently, new therapeutic targets aiming at inhibiting IL-4R using monoclonal antibodies and JAK inhibitors are developed [137,138], while the inhibition of IL-13 using monoclonal antibodies attenuates the itch in AD [18,19].”
BackgroundMethodPathophysiology of atopic dermatitis: Clinical implications
Kim, J., Kim, B. E., & Leung, D. Y. M. (2019) · Allergy and Asthma Proceedings · doi:10.2500/aap.2019.40.4202 · Cited by 635 · cited 2×
“Furthermore, FLG and LOR, involucrin, and keratins 1,10 are downregulated in the presence of T2 inflammation cytokines, such as IL-4, IL-13, IL-22, and IL-31, in a process mediated by OVO-like 1 (OVOL1), an upstream transcription factor for these proteins [49,57].”
BackgroundAtopic dermatitis: an expanding therapeutic pipeline for a complex disease
Bieber, T. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00266-6 · Cited by 623 · cited 1×
“The exposome is the “master regulator” in the interplay between a disrupted and “leaky” epithelium barrier, microbiome, genome, and immune dysregulation in AD [ 112].”
BackgroundGuttman-Yassky, E., Teixeira, H. D., Simpson, E. L., Papp, K. A., Pangan, A. L., Blauvelt, A., Thaçi, D., Chu, C.-Y., Hong, H. C.-H., Katoh, N., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00588-2 · Cited by 583 · cited 1×
“Subsequently, new therapeutic targets aiming at inhibiting IL-4R using monoclonal antibodies and JAK inhibitors are developed [137,138], while the inhibition of IL-13 using monoclonal antibodies attenuates the itch in AD [18,19].”
BackgroundStaphylococcus δ-toxin induces allergic skin disease by activating mast cells
Nakamura, Y., Oscherwitz, J., Cease, K. B., Chan, S. M., Muñoz-Planillo, R., Hasegawa, M., Villaruz, A. E., Cheung, G. Y. C., McGavin, M. J., Travers, J. B., et al. (2013) · Nature · doi:10.1038/nature12655 · Cited by 558
Wollenberg, A., Christen‐Zäch, S., Taieb, A., Paul, C., Thyssen, J. P., de Bruin‐Weller, M., Vestergaard, C., Seneschal, J., Werfel, T., Cork, M. J., et al. (2020) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16892 · Cited by 493 · cited 1×
“Atopic dermatitis (AD) is the most common inflammatory skin disorder, affecting up to 25% of children and 10% of adults, depending on the geographical area [1].”
BackgroundCelebi Sozener, Z., Ozdel Ozturk, B., Cerci, P., Turk, M., Gorgulu Akin, B., Akdis, M., Altiner, S., Ozbey, U., Ogulur, I., Mitamura, Y., et al. (2022) · Allergy · doi:10.1111/all.15240 · Cited by 418
Tapinarof is a natural AhR agonist that resolves skin inflammation in mice and humans.
Smith, S. H., Jayawickreme, C., Rickard, D. J., Nicodeme, E., Bui, T., Simmons, C., Coquery, C. M., Neil, J., Pryor, W. M., Mayhew, D., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.05.004 · Cited by 387 · cited 1×
“…to AHR and up-regulating the expression of barrier protein genes and skin integrity, such as tapinarof, a small molecule produced by bacteria, diosmin, a natural agonist derived from the Ruta-cae family, and other medical remedies, such as Rhodiola crenulate and Artemisia princeps [60,75–77].”
BackgroundMeixiong, J., Anderson, M., Limjunyawong, N., Sabbagh, M. F., Hu, E., Mack, M. R., Oetjen, L. K., Wang, F., Kim, B. S., & Dong, X. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.013 · Cited by 369 · cited 2×
“Moreover, neuro-transmitters released from nerve fibers can modulate the immune system in the skin and vice versa [149,150].”
BackgroundGuttman-Yassky, E., Thaçi, D., Pangan, A. L., Hong, H. C.-H., Papp, K. A., Reich, K., Beck, L. A., Mohamed, M.-E. F., Othman, A. A., Anderson, J. K., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.11.025 · Cited by 369 · cited 2×
“Upadacitinib and baricitinib have been licensed for adolescents/adults and children from the age of 2 years with moderate to severe AD, respectively [25,26].”
BackgroundNakatsuji, T., Chen, T. H., Two, A. M., Chun, K. A., Narala, S., Geha, R. S., Hata, T. R., & Gallo, R. L. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.05.127 · Cited by 362 · cited 1×
“Furthermore, excessive colonization of S. aureus on the skin leads to biofilm formation and secretion of virulence factors, which further stimulate keratinocytes and Langerhans cells to release T2 inflammatory responses [ 84,85].”
BackgroundGuttman-Yassky, E., Blauvelt, A., Eichenfield, L. F., Paller, A. S., Armstrong, A. W., Drew, J., Gopalan, R., & Simpson, E. L. (2020) · JAMA Dermatology · doi:10.1001/jamadermatol.2020.0079 · Cited by 341
Piao, M. J., Ahn, M. J., Kang, K. A., Ryu, Y. S., Hyun, Y. J., Shilnikova, K., Zhen, A. X., Jeong, J. W., Choi, Y. H., Kang, H. K., et al. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2197-9 · Cited by 339 · cited 1×
“Exposure to high concentrations of PM 2.5 (meaning 2.5 µm in diameter) emitted during wildfires disrupts skin epithelium barriers by damaging the structural proteins (FLG, E-cadherin), and lipids in the epidermis [118,119].”
BackgroundInfluentialJAK–STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review
Huang, I.-H., Chung, W.-H., Wu, P.-C., & Chen, C.-B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1068260 · Cited by 329 · cited 2×
“The JAK family consists of four intracellular kinases, JAK1, JAK2, JAK3, and TYK2, which are activated in pairs when cytokines bind to their respective receptors [20].”
BackgroundSimpson, E. L., Parnes, J. R., She, D., Crouch, S., Rees, W., Mo, M., & van der Merwe, R. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.11.059 · Cited by 328 · cited 1×
“…improvement in the pruritus rating scale (NRS), Investigator’s Global Assessment (IGA), and also 50% and 75% reductions in the Eczema Area and Severity Index (EASI50 and EASI75, respectively), with 50% and 75% reductions in the SCORing AD index (SCORAD50 and SCORAD75, respectively) [141].”
MethodFirst-in-human topical microbiome transplantation with Roseomonas mucosa for atopic dermatitis
Myles, I. A., Earland, N. J., Anderson, E. D., Moore, I. N., Kieh, M. D., Williams, K. W., Saleem, A., Fontecilla, N. M., Welch, P. A., Darnell, D. A., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.120608 · Cited by 326 · cited 1×
“Roseomonas mucosa , a Gram-negative skin commensal, contributes to tissue repair through sphingolipid production and stimulating cholinergic signaling and to flagellin expression through the TNF-mediated signaling pathway, thereby ameliorating AD symptoms [ 102, 103].”
BackgroundDaily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial
Chalmers, J. R., Haines, R. H., Bradshaw, L. E., Montgomery, A. A., Thomas, K. S., Brown, S. J., Ridd, M. J., Lawton, S., Simpson, E. L., Cork, M. J., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(19)32984-8 · Cited by 317 · cited 1×
“However, the long-term effect of emollients on the microbiome and skin pH is still debated [98,99].”
BackgroundPapp, K., Szepietowski, J. C., Kircik, L., Toth, D., Eichenfield, L. F., Leung, D. Y. M., Forman, S. B., Venturanza, M. E., Sun, K., Kuligowski, M. E., et al. (2021) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2021.04.085 · Cited by 313
Wollenberg, A., Kinberger, M., Arents, B., Aszodi, N., Avila Valle, G., Barbarot, S., Bieber, T., Brough, H. A., Calzavara Pinton, P., Christen‐Zäch, S., et al. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.18429 · Cited by 289 · cited 2×
“Current prebiotic, probiotic, and postbiotic formulations have limited evidence regarding the guidelines to allow a recommendation for their use as therapeutic agents in AD [93].”
BackgroundSelf-citationZheng, Y., Hunt, R. L., Villaruz, A. E., Fisher, E. L., Liu, R., Liu, Q., Cheung, G. Y. C., Li, M., & Otto, M. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.01.004 · Cited by 285 · cited 1×
“Staphylococcus ( S ). epidermidis represents the most abundant species in human skin, facilitating the defense against other pathogens and contributing to skin epithelialization, while such responses are also induced by Corynebacterium, Propionibacterium, and Streptococcus sp. [81].”
BackgroundLipid abnormalities in atopic skin are driven by type 2 cytokines
Berdyshev, E., Goleva, E., Bronova, I., Dyjack, N., Rios, C., Jung, J., Taylor, P., Jeong, M., Hall, C. F., Richers, B. N., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.98006 · Cited by 283 · cited 2×
“The lipid chain length of ceramides and free fatty acids and the levels of elongases 3 and 6 (ELOVL3, ELOVL6), which play a significant role in lipid chain elongation, is decreased in both the lesional and non-lesional AD skin [ 51,52].”
BackgroundMcInnes, I. B., Byers, N. L., Higgs, R. E., Lee, J., Macias, W. L., Na, S., Ortmann, R. A., Rocha, G., Rooney, T. P., Wehrman, T., et al. (2019) · Arthritis Research & Therapy · doi:10.1186/s13075-019-1964-1 · Cited by 281 · cited 1×
“In this respect, the beneficial effects of upadacitinib might also be attributed to the downregulation of IL-21 [25,37].”
BackgroundPaller, A. S., Simpson, E. L., Siegfried, E. C., Cork, M. J., Wollenberg, A., Arkwright, P. D., Soong, W., Gonzalez, M. E., Schneider, L. C., Sidbury, R., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01539-2 · Cited by 281 · cited 1×
“…dupilumab’s safety, tolerability, and efficacy in all age groups, while pediatric studies have also shown significant improvements in validated scores, assessing symptoms and signs in AD patients, and, interestingly, decreasing the likelihood of skin infections in preschool-aged children [15–17].”
Novel insights into atopic dermatitis
Schuler, C. F., Billi, A. C., Maverakis, E., Tsoi, L. C., & Gudjonsson, J. E. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.10.023 · Cited by 281 · cited 1×
“…dysregulated immune activation as the primary trigger in the pathophysiology of AD, are now integrated into a complex and multifaceted model, including the genetic component and, the effect of environmental pollutants, in the context of a dysregulated T H 2 and T H 17 skewed immune response [4].”
BackgroundUpdate on the Pathogenesis and Therapy of Atopic Dermatitis
Li, H., Zhang, Z., Zhang, H., Guo, Y., & Yao, Z. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08880-3 · Cited by 277
Yu, J., Luo, Y., Zhu, Z., Zhou, Y., Sun, L., Gao, J., Sun, J., Wang, G., Yao, X., & Li, W. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.11.036 · Cited by 255 · cited 1×
“Aryl hydrocarbon receptor (AHR) is a ligand-dependent transcription factor that controls skin barrier protein activation by regulating the epidermal differentiation complex (EDC) [74].”
BackgroundReich, K., Thyssen, J. P., Blauvelt, A., Eyerich, K., Soong, W., Rice, Z. P., Hong, H. C.-H., Katoh, N., Valenzuela, F., DiBonaventura, M., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01199-0 · Cited by 251 · cited 1×
“Abrocitinib is a safe and effective therapeutic agent, currently approved for adults and adolescents in the USA and UK with moderate to severe AD, while approval for 12 to 18-year-old AD patients is currently awaited in Europe [22–24].”
BackgroundMeylan, P., Lang, C., Mermoud, S., Johannsen, A., Norrenberg, S., Hohl, D., Vial, Y., Prod’hom, G., Greub, G., Kypriotou, M., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.07.834 · Cited by 248 · cited 1×
“IL-13 decreases antimicrobial peptides and promotes epidermal dysbiosis [106].”
BackgroundNakagawa, H., Nemoto, O., Igarashi, A., Saeki, H., Kaino, H., & Nagata, T. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.12.015 · Cited by 242 · cited 1×
“Delgocitinib, a pan-Janus kinase inhibitor in an ointment form, has been approved for moderate to severe adult chronic hand eczema and is still under trial for atopic dermatitis in the pediatric population [28].”
BackgroundCallewaert, C., Nakatsuji, T., Knight, R., Kosciolek, T., Vrbanac, A., Kotol, P., Ardeleanu, M., Hultsch, T., Guttman-Yassky, E., Bissonnette, R., et al. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.05.024 · Cited by 223 · cited 1×
“In this respect, the anti-IL4/IL-13 monoclonal antibody, Dupilumab, improves skin dysbiosis by inhibiting S. aureus growth and restoring microbial skin dysbiosis; meanwhile, it also increases S. epider-midis and S. hominis [62,107].”
BackgroundDupilumab for treatment of atopic dermatitis
Seegräber, M., Srour, J., Walter, A., Knop, M., & Wollenberg, A. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1449642 · Cited by 222
STAT3-dependent reactive astrogliosis in the spinal dorsal horn underlies chronic itch
Shiratori-Hayashi, M., Koga, K., Tozaki-Saitoh, H., Kohro, Y., Toyonaga, H., Yamaguchi, C., Hasegawa, A., Nakahara, T., Hachisuka, J., Akira, S., et al. (2015) · Nature Medicine · doi:10.1038/nm.3912 · Cited by 218 · cited 1×
“Moreover, IL-31 activates STAT3 in astrocytes via lipocalin-2 production, enhancing additional itch signals in the spinal cord [143].”
BackgroundTauber, M., Balica, S., Hsu, C.-Y., Jean-Decoster, C., Lauze, C., Redoules, D., Viodé, C., Schmitt, A.-M., Serre, G., Simon, M., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.07.052 · Cited by 215 · cited 1×
“The skin microbiome in AD patients is dysbiotic, defined by imbalanced bacterial composition and diversity [57,79], with reduced commensals, while the increased number of skin pathogens has been positively associated with AD severity [80].”
BackgroundExternal exposome and allergic respiratory and skin diseases
Cecchi, L., D'Amato, G., & Annesi-Maesano, I. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.01.016 · Cited by 209 · cited 1×
“…with a high degree of overlap, as the general external: Climate, biodiversity, urbanization, and socioeconomic con-texts; the specific external: allergens, pollutants, tobacco smoke, diet, lifestyle factors, and microbes; the internal: Inflammation, metabolism, and oxidative stress exposome [ 111].”
BackgroundAtopic dermatitis in African American patients is TH2/TH22-skewed with TH1/TH17 attenuation
Sanyal, R. D., Pavel, A. B., Glickman, J., Chan, T. C., Zheng, X., Zhang, N., Cueto, I., Peng, X., Estrada, Y., Fuentes-Duculan, J., et al. (2019) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2018.08.024 · Cited by 207
Brunner, P. M., Pavel, A. B., Khattri, S., Leonard, A., Malik, K., Rose, S., Jim On, S., Vekaria, A. S., Traidl-Hoffmann, C., Singer, G. K., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.07.028 · Cited by 201 · cited 1×
“Blockade of IL-22 using the monoclonal antibody Fezakinumab down-regulates multiple immune pathways associated with AD, such as T H 1, T H 2, T H 17, and T H 22, in patients with high serum IL-22 levels and has been proven safe and efficient in individuals with severe AD [39].”
New mechanism underlying IL-31–induced atopic dermatitis
Meng, J., Moriyama, M., Feld, M., Buddenkotte, J., Buhl, T., Szöllösi, A., Zhang, J., Miller, P., Ghetti, A., Fischer, M., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.12.1002 · Cited by 191 · cited 1×
“Furthermore, IL-31 promotes the release of brain-derived natriuretic peptide (BNP) from the dorsal root ganglionic neurons and skin cells, contributing to the itchy sensation [144].”
BackgroundVu, A. T., Baba, T., Chen, X., Le, T. A., Kinoshita, H., Xie, Y., Kamijo, S., Hiramatsu, K., Ikeda, S., Ogawa, H., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.09.002 · Cited by 186 · cited 1×
“Furthermore, excessive colonization of S. aureus on the skin leads to biofilm formation and secretion of virulence factors, which further stimulate keratinocytes and Langerhans cells to release T2 inflammatory responses [ 84,85].”
BackgroundThe IL-4, IL-13 and IL-31 pathways in atopic dermatitis
Dubin, C., Del Duca, E., & Guttman-Yassky, E. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1940962 · Cited by 181 · cited 1×
“Moreover, they contribute to the neurogenic itch by directly stimulating pruritogenic sensory neurons, as will be further discussed later [12].”
BackgroundNeuroimmune interactions in chronic itch of atopic dermatitis
Yosipovitch, G., Berger, T., & Fassett, M. S. (2020) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.15973 · Cited by 173 · cited 1×
“More recently, the Mas-related G-protein-coupled receptor X2 (MRGPRX2) on the surface of mast cells, basophils, and eosinophils has been implicated in the itch pathogenesis as an itch receptor [151].”
BackgroundExacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber
Werfel, T., Heratizadeh, A., Niebuhr, M., Kapp, A., Roesner, L. M., Karch, A., Erpenbeck, V. J., Lösche, C., Jung, T., Krug, N., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.04.015 · Cited by 171 · cited 1×
“Most importantly, climate change has altered and prolonged pollen season, whereas air pollution determinants, such as NO 2 , act as an adjuvant to the airborne allergens, thereby increasing their allergenicity and contributing to exacerbation in AD [124].”
BackgroundEichenfield, L. F., Flohr, C., Sidbury, R., Siegfried, E., Szalai, Z., Galus, R., Yao, Z., Takahashi, H., Barbarot, S., Feeney, C., et al. (2021) · JAMA Dermatology · doi:10.1001/jamadermatol.2021.2830 · Cited by 169
Revisiting the Roles of Filaggrin in Atopic Dermatitis
Moosbrugger-Martinz, V., Leprince, C., Méchin, M.-C., Simon, M., Blunder, S., Gruber, R., & Dubrac, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105318 · Cited by 168 · cited 1×
“During FLG degradation, the newly formed urocanic acid and pyrrolidine carboxylic acid contribute to SC hydration, thus, preserving skin integrity [53].”
BackgroundDiverse Regulation of Claudin-1 and Claudin-4 in Atopic Dermatitis
Gruber, R. W., Börnchen, C., Rose, K., Daubmann, A., Volksdorf, T., Wladykowski, E., Vidal‐y‐Sy, S., Peters, E. M. J., Danso, M. O., Bouwstra, J. A., et al. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.06.021 · Cited by 165 · cited 1×
“Tight junctions (TJs) form a complex intracellular barrier in the SG, while claudin is the major adhesion structural protein in TJs. Downregulation of claudins and the presence of single nucleotide polymorphisms in the CLDN1 gene lead to TJ defects and increased TEWL in patients with AD [ 66].”
BackgroundManagement of atopic dermatitis: safety and efficacy of phototherapy
Patrizi, A., Raone, B., & Ravaioli, G. M. (2015) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s87987 · Cited by 160 · cited 1×
“In accordance, a follow-up birth cohort study (T-CHEQ) showed that early exposure to NO 2 and O 3 was associated with an increased risk of AD occurrence in children (hazard ratio 1.07, 95% CI 0.99–1.15) [ 115,116].”
BackgroundInfluentialYamaguchi, J., Aihara, M., Kobayashi, Y., Kambara, T., & Ikezawa, Z. (2008) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2008.08.011 · Cited by 159 · cited 1×
“NGF levels are strongly associated with itch severity and AD eruptions [148].”
BackgroundBlauvelt, A., Silverberg, J. I., Lynde, C. W., Bieber, T., Eisman, S., Zdybski, J., Gubelin, W., Simpson, E. L., Valenzuela, F., Criado, P. R., et al. (2022) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2021.05.075 · Cited by 159
Early life exposure to air pollution and incidence of childhood asthma, allergic rhinitis and eczema
To, T., Zhu, J., Stieb, D., Gray, N., Fong, I., Pinault, L., Jerrett, M., Robichaud, A., Ménard, R., van Donkelaar, A., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00913-2019 · Cited by 156 · cited 1×
“In accordance, a follow-up birth cohort study (T-CHEQ) showed that early exposure to NO 2 and O 3 was associated with an increased risk of AD occurrence in children (hazard ratio 1.07, 95% CI 0.99–1.15) [ 115,116].”
BackgroundInfluentialDanso, M. O., Boiten, W. A., van Drongelen, V., Meijling, K. A. G., Gooris, G. S., Ghalbzouri, A. E., Absalah, S., Vreeken, R. J., Kežić, S., van Smeden, J., et al. (2017) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2017.05.005 · Cited by 149 · cited 2×
“The lipid chain length of ceramides and free fatty acids and the levels of elongases 3 and 6 (ELOVL3, ELOVL6), which play a significant role in lipid chain elongation, is decreased in both the lesional and non-lesional AD skin [ 51,52].”
BackgroundKabashima, K., Matsumura, T., Komazaki, H., Kawashima, M., & for the Nemolizumab JP01 andJP02 Study Group (2021) · British Journal of Dermatology · doi:10.1111/bjd.20873 · Cited by 146
Vinhas, R., Cortes, L., Cardoso, I., Mendes, V. M., Manadas, B., Todo-Bom, A., Pires, E., & Veríssimo, P. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02598.x · Cited by 145 · cited 1×
“Moreover, allergens with proteolytic activity, such as certain pollens and group 1 house dust mites, disrupt barriers and contribute to the vicious cycle of inflammation, microbiome dysbiosis, and epithelium leakage [125].”
BackgroundLou, H., Lu, J., Choi, E. B., Oh, M. H., Jeong, M., Barmettler, S., Zhu, Z., & Zheng, T. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1600126 · Cited by 140 · cited 1×
“…AD, impairs the skin barrier by suppressing proteins critical for epidermal differentiation, enhances antigen sensitization, and promotes a biased T2 immune response, while it contributes to the pathogenesis of chronic itching in AD by promoting the expression of itch-inducing cytokines [ 38].”
BackgroundSimpson, E. L., Forman, S., Silverberg, J. I., Zirwas, M., Maverakis, E., Han, G., Guttman-Yassky, E., Marnell, D., Bissonnette, R., Waibel, J., et al. (2021) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2021.02.028 · Cited by 140 · cited 1×
“Upadacitinib and baricitinib have been licensed for adolescents/adults and children from the age of 2 years with moderate to severe AD, respectively [25,26].”
BackgroundWerfel, T., Layton, G., Yeadon, M., Whitlock, L., Osterloh, I., Jimenez, P., Liu, W., Lynch, V., Asher, A., Tsianakas, A., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.07.047 · Cited by 139
Myles, I. A., Castillo, C. R., Barbian, K. D., Kanakabandi, K., Virtaneva, K., Fitzmeyer, E., Paneru, M., Otaizo-Carrasquero, F., Myers, T. G., Markowitz, T. E., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz8631 · Cited by 139 · cited 1×
“Roseomonas mucosa , a Gram-negative skin commensal, contributes to tissue repair through sphingolipid production and stimulating cholinergic signaling and to flagellin expression through the TNF-mediated signaling pathway, thereby ameliorating AD symptoms [ 102, 103].”
BackgroundJang, H., Matsuda, A., Jung, K., Karasawa, K., Matsuda, K., Oida, K., Ishizaka, S., Ahn, G., Amagai, Y., Moon, C., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.363 · Cited by 134 · cited 1×
“…mutations are the most important genetic risk factors for AD due to alterations in lipid delivery, the decrease in FLG monomers, and natural moisturizing factors produced by FLG metabolites [54,55], while the resulting altered skin pH leads to impaired lipid construction and cell apoptosis [56].”
BackgroundBasics and recent advances in the pathophysiology of atopic dermatitis
Nakahara, T., Kido‐Nakahara, M., Tsuji, G., & Furue, M. (2021) · The Journal of Dermatology · doi:10.1111/1346-8138.15664 · Cited by 130 · cited 2×
“Furthermore, FLG and LOR, involucrin, and keratins 1,10 are downregulated in the presence of T2 inflammation cytokines, such as IL-4, IL-13, IL-22, and IL-31, in a process mediated by OVO-like 1 (OVOL1), an upstream transcription factor for these proteins [49,57].”
BackgroundConfirmation of multiple endotypes in atopic dermatitis based on serum biomarkers
Bakker, D. S., Nierkens, S., Knol, E. F., Giovannone, B., Delemarre, E. M., van der Schaft, J., van Wijk, F., de Bruin-Weller, M. S., Drylewicz, J., & Thijs, J. L. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.04.062 · Cited by 126 · cited 1×
“…17, and epithelial-related chemokines, the third T H 2, T H 22, and pulmonary and activation-regulated chemokine (PARC) dominated cluster, which was associated with significantly more severe disease, and the fourth, a T H 2 and eosinophil-inferior cluster, with the least inflammatory disease [155].”
BackgroundYepes-Núñez, J. J., Guyatt, G. H., Gómez-Escobar, L. G., Pérez-Herrera, L. C., Chu, A. W. L., Ceccacci, R., Acosta, A. S., Wen, A., Moreno, S., MacDonald, M., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.09.020 · Cited by 117 · cited 1×
“Recently, the role of airborne allergens in AD pathogenesis has been suggested by the beneficial effects of aeroallergen immunotherapy in patients with AD, which reduces severity and improves quality of life [126].”
BackgroundEmollient use alters skin barrier and microbes in infants at risk for developing atopic dermatitis
Glatz, M., Jo, J.-H., Kennedy, E. A., Polley, E. C., Segre, J. A., Simpson, E. L., & Kong, H. H. (2018) · PLOS ONE · doi:10.1371/journal.pone.0192443 · Cited by 115 · cited 1×
“However, the long-term effect of emollients on the microbiome and skin pH is still debated [98,99].”
BackgroundPAR2 Mediates Itch via TRPV3 Signaling in Keratinocytes
Zhao, J., Munanairi, A., Liu, X.-Y., Zhang, J., Hu, L., Hu, M., Bu, D., Liu, L., Xie, Z., Kim, B. S., et al. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.01.012 · Cited by 115 · cited 1×
“Furthermore, activation of the TRPV3 and T cells can further augment TSLP production and the itch sensation [140].”
BackgroundAtopic dermatitis in Chinese patients shows TH2/TH17 skewing with psoriasiform features
Chan, T. C., Sanyal, R. D., Pavel, A. B., Glickman, J., Zheng, X., Xu, H., Cho, Y.-T., Tsai, T.-F., Wen, H.-C., Peng, X., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.06.016 · Cited by 114 · cited 1×
“Moreover, AD in Asia is characterized by combined T H 2/T H 17 upregulation and features such as psoriasis [158] and less T H 1 expression compared to European Americans [159], indicating that racial differences need to be assessed when managing patients with more severe forms of AD.”
Distribution of IL-31 and its receptor expressing cells in skin of atopic dermatitis
Kato, A., Fujii, E., Watanabe, T., Takashima, Y., Matsushita, H., Furuhashi, T., & Morita, A. (2014) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2014.02.009 · Cited by 110 · cited 1×
“The so-called “itch cytokine” IL-31 is a major pru-ritogenic component in AD, which binds to its receptor in the peripheral sensory nerve fibers in the epidermis and dermis and enhances the secretion of other prurito-gens [142].”
BackgroundAgache, I., Miller, R., Gern, J. E., Hellings, P. W., Jutel, M., Muraro, A., Phipatanakul, W., Quirce, S., & Peden, D. (2019) · Allergy · doi:10.1111/all.13690 · Cited by 110 · cited 1×
“Within this concept, distinct exposures include allergens, pollutants, irritants, lifestyle choices, diet, stress, socioeconomic parameters, climate change, microbial agents, etc. [110].”
BackgroundThe IL‐13–OVOL 1–FLG axis in atopic dermatitis
Furue, K., Ito, T., Tsuji, G., Ulzii, D., Vu, Y. H., Kido‐Nakahara, M., Nakahara, T., & Furue, M. (2019) · Immunology · doi:10.1111/imm.13120 · Cited by 107 · cited 1×
“Specifically, OVOL1 activation induces translocation from the cytoplasm to the nucleus and upregulates FLG, while interference by the inflammatory cytokines on OVOL1 decreases FLG expression [59].”
BackgroundTH2 cytokines increase kallikrein 7 expression and function in patients with atopic dermatitis
Morizane, S., Yamasaki, K., Kajita, A., Ikeda, K., Zhan, M., Aoyama, Y., Gallo, R. L., & Iwatsuki, K. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.03.006 · Cited by 101 · cited 1×
“Moreover, IL-4 and IL-13 induce kallikrein (KLK-7) in normal keratinocytes, which mediates the itch pathogenesis via skin–neural mechanisms [135].”
BackgroundHashimoto, T., Yokozeki, H., Karasuyama, H., & Satoh, T. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.11.009 · Cited by 96 · cited 4×
“Notably, the interleukin (IL)-31 network, comprising several cell types, such as macrophages, basophils, and the generated cytokines, is also involved in the pathogenesis of the itchiness in AD [8].”
BackgroundInfluentialLeech, J. M., Dhariwala, M. O., Lowe, M. M., Chu, K., Merana, G. R., Cornuot, C., Weckel, A., Ma, J. M., Leitner, E. G., Gonzalez, J. R., et al. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.10.007 · Cited by 95
Akdis, C. A. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.11.010 · Cited by 95
The Role of the Environment and Exposome in Atopic Dermatitis
Stefanovic, N., Irvine, A. D., & Flohr, C. (2021) · Current Treatment Options in Allergy · doi:10.1007/s40521-021-00289-9 · Cited by 94 · cited 1×
“Such reduction and compromised functionality of Tregs might also be attributed to exposure to tobacco smoke during pregnancy and microbiome dysbiosis [31,32].”
BackgroundLunjani, N., Hlela, C., & O’Mahony, L. (2019) · Current Opinion in Allergy & Clinical Immunology · doi:10.1097/aci.0000000000000542 · Cited by 93 · cited 1×
“Skin is inhabited by a complex community of bacteria, fungi, and viruses, which constitute the skin microbiota and impose immunomodulatory and protective effects against pathogenetic microbes [78].”
BackgroundMarschall, P., Wei, R., Segaud, J., Yao, W., Hener, P., German, B., Meyer, P., Hugel, C., Silva, G. A. D., Braun, R., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.10.006 · Cited by 92 · cited 1×
“The release of TSLP by epidermal cells is upregulated by activated T cells and crosstalk with other immune cells [139].”
BackgroundMashiah, J., Karady, T., Isakov, N. F., Sprecher, E., Slodownik, D., Artzi, O., Samuelov, L., Ellenbogen, E., Godneva, A., Segal, E., et al. (2021) · Immunity Inflammation and Disease · doi:10.1002/iid3.570 · Cited by 81 · cited 1×
“Autologous microbiotherapy is an evolving treatment option with satisfactory results and only minor adverse effects [100].”
BackgroundAdult atopic dermatitis and exposure to air pollutants—a nationwide population-based study
Tang, K.-T., Ku, K.-C., Chen, D.-Y., Lin, C.-H., Tsuang, B.-J., & Chen, Y.-H. (2017) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2016.12.005 · Cited by 73 · cited 1×
“Exposure to high concentrations of PM 2.5 (meaning 2.5 µm in diameter) emitted during wildfires disrupts skin epithelium barriers by damaging the structural proteins (FLG, E-cadherin), and lipids in the epidermis [118,119].”
BackgroundInfluentialWen, H.-C., Czarnowicki, T., Noda, S., Malik, K., Pavel, A. B., Nakajima, S., Honda, T., Shin, J. U., Lee, H., Chou, M., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.02.047 · Cited by 73 · cited 1×
“Moreover, AD in Asia is characterized by combined T H 2/T H 17 upregulation and features such as psoriasis [158] and less T H 1 expression compared to European Americans [159], indicating that racial differences need to be assessed when managing patients with more severe forms of AD.”
BackgroundSeite, S., ZELENKOVA, H., & MARTIN, R. (2017) · Clinical, Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s121910 · Cited by 72
Saeki, H., Baba, N., Ito, K., Yokota, D., & Tsubouchi, H. (2021) · British Journal of Dermatology · doi:10.1111/bjd.20655 · Cited by 71 · cited 1×
“…for topical treatment in patients older than two years old with mild to moderate diseases [40], while another promising selective PDE4 inhibitor, Difamilast (also OPA-15406 or MM36), has undergone phase II trials in pediatric and adult patients with mild-to-moderate AD, with positive results [41].”
BackgroundButala, S., Castelo‐Soccio, L. A., Seshadri, R., Simpson, E. L., O’Shea, J. J., Bieber, T. R. M., & Paller, A. S. (2023) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2023.03.011 · Cited by 71 · cited 1×
“…dupilumab’s safety, tolerability, and efficacy in all age groups, while pediatric studies have also shown significant improvements in validated scores, assessing symptoms and signs in AD patients, and, interestingly, decreasing the likelihood of skin infections in preschool-aged children [15–17].”
Bleach baths for atopic dermatitis
Bakaa, L., Pernica, J. M., Couban, R., Tackett, K. J., Burkhart, C. N., Leins, L., Smart, J. M., García‐Romero, M. T., Elizalde-Jiménez, I. G., Herd, M., et al. (2022) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2022.03.024 · Cited by 70 · cited 1×
“Thus, they should be used cautiously since adverse effects might be noted [94].”
BackgroundWang, X., Jiang, X., Yu, X., Liu, H., Tao, Y., Jiang, G., & Hong, M. H. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13204 · Cited by 69 · cited 1×
“Glucoseskin application in high concentrations can increase claudin-1 and FLG production [68], while Cimifugin, a bioactive Chinese herb, and the orally admin-istrated PAG (DL-propargylglycine) improve TJs function by suppressing allergic inflammation [69,70].”
BackgroundKeam, S. J. (2022) · Drugs · doi:10.1007/s40265-022-01741-z · Cited by 68 · cited 1×
“…receptor, showing that subcutaneous administration of Nemolizumab in addition to topical agents, effectively improves pruritus compared to the placebo in individuals with AD; thus, it has been granted approval in adults and adolescents for the treatment of itching associated with AD [145,146].”
BackgroundPark, S., & Bae, J.-H. (2015) · Nutrition Research · doi:10.1016/j.nutres.2015.11.011 · Cited by 67 · cited 1×
“Westernization in dietary habits has been consistently associated with AD development and severity [127].”
BackgroundEffects of oral vitamin E on treatment of atopic dermatitis: A randomized controlled trial
Faghihi, G., Jaffary, F., Mokhtarian, A., & Hosseini, S. (2015) · Journal of Research in Medical Sciences · doi:10.4103/1735-1995.172815 · Cited by 67 · cited 1×
“Increased consumption of processed foods is correlated with AD severity, while low vitamin C and E intakes are inversely associated with AD [128,129].”
BackgroundNakatsuji, T., Gallo, R. L., Shafiq, F., Tong, Y., Chun, K., Butcher, A. M., Cheng, J. Y., & Hata, T. R. (2021) · JAMA Dermatology · doi:10.1001/jamadermatol.2021.1311 · Cited by 67 · cited 1×
“( S. epidermidis , S. hominis , S. warneri , S. capitis ) that can grow on the healthy skin of AD patients [101].”
BackgroundBlood transcriptome profiling identifies 2 candidate endotypes of atopic dermatitis
Möbus, L., Rodríguez, E., Harder, I., Sander, N., Szymczak, S., Hübenthal, M., Stölzl, D., Gerdes, S., Kleinheinz, A., Abraham, S., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.02.001 · Cited by 67 · cited 2×
“Blood transcriptome analysis proposed two AD endo-types based on the eosinophil-related expression signature [ 154].”
BackgroundMethodSTAT6 gain-of-function variant exacerbates multiple allergic symptoms
Takeuchi, I., Yanagi, K., Takada, S., Uchiyama, T., Igarashi, A., Motomura, K., Hayashi, Y., Nagano, N., Matsuoka, R., Sugiyama, H., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.12.802 · Cited by 67 · cited 1×
“STAT6 upregulates the expression of the T2-specific transcription factor GATA3 and promotes a class switch to IgE in B cells, hence, regulating T cell proliferation and T2 differentiation [21].”
BackgroundAnalysis of the skin mycobiome in adult patients with atopic dermatitis
Han, S. H., Cheon, H. I., Hur, M. S., Kim, M. J., Jung, W. H., Lee, Y. W., Choe, Y. B., & Ahn, K. J. (2018) · Experimental Dermatology · doi:10.1111/exd.13500 · Cited by 66 · cited 1×
“[ 89,90].”
Basophils promote barrier dysfunction and resolution in the atopic skin
Pellefigues, C., Naidoo, K., Mehta, P., Schmidt, A. J., Jagot, F., Roussel, E., Cait, A., Yumnam, B., Chappell, S., Meijlink, K., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.02.018 · Cited by 66 · cited 1×
“Basophils participate in the initiation of AD through increased expression of IL-4 and interactions with keratinocytes and dermal macrophages, resulting in epider-3 mal hyperplasia and skin barrier dysfunction [42].”
BackgroundZhang, C., Chinnappan, M., Prestwood, C. A., Edwards, M., Artami, M., Thompson, B. M., Eckert, K. M., do Vale, G. D., Zouboulis, C. C., McDonald, J. G., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2100749118 · Cited by 64 · cited 1×
“…in decreased levels of triglyceride concentration in sebocytes and keratinocytes within the epidermis, further damaging the atopic skin; thus, inhibition of 3 β - hydroxysteroid dehydrogenase-1 could serve as a potential therapeutic target, by restoring triglyceride content in the human skin [13].”
BackgroundInterleukin-18 and IL-18BP in inflammatory dermatological diseases
Wang, X., Wang, L., Wen, X., Zhang, L., Jiang, X. L., & He, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.955369 · Cited by 64 · cited 1×
“Elevated IL-18 levels have been associated with increased AD morbidity, while IL-18 deficiency in murine models ameliorated AD skin lesions by decreasing IL-4 levels and mast cell infiltration [33,34].”
BackgroundLeyva-Castillo, J. M., Das, M., Artru, E., Yoon, J., Galand, C., & Geha, R. S. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.11.036 · Cited by 61 · cited 2×
“Induction of IL-13 by cutaneous mast cells in response to the damaged skin directly inhibits the T H 1-associated interleukin IL-12 and the subsequent IFN-γ release from CD4+ T cells, suppressing T H 1-mediated immune response to cutaneous encountered antigens in AD [14].”
BackgroundMethodGuseva, D., Rüdrich, U., Kotnik, N., Gehring, M., Patsinakidis, N., Agelopoulos, K., Ständer, S., Homey, B., Kapp, A., Gibbs, B. F., et al. (2020) · Clinical & Experimental Allergy · doi:10.1111/cea.13560 · Cited by 60 · cited 1×
“An increased density of sensory neurons is noted in the skin of AD patients, resulting in exacerbated responses to a variety of pruritogens, such as neurotrophins (nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF)) [147].”
BackgroundKonstantinou, G. Ν., Konstantinou, G., Koulias, C., Petalas, K., & Makris, M. P. (2022) · Journal of Asthma and Allergy · doi:10.2147/jaa.s282039 · Cited by 60 · cited 1×
“Moreover, neuro-transmitters released from nerve fibers can modulate the immune system in the skin and vice versa [149,150].”
BackgroundSelf-citationMoriya, C., Jinnin, M., Yamane, K., Maruo, K., Muchemwa, F. C., Igata, T., Makino, T., Fukushima, S., & Ihn, H. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.361 · Cited by 59 · cited 1×
“IL-13 IL-13 also inhibits involucrin in an OVOL1-independent way, promoting barrier dysfunction [60], while it reduces the expression of skin barrier proteins and lipids by acting on keratinocytes, regulating the expression of metalloproteinase (MMP)-9 [61].”
BackgroundHashimoto-Hachiya, A., Tsuji, G., Murai, M., Yan, X., & Furue, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061654 · Cited by 58 · cited 3×
“IL-13 IL-13 also inhibits involucrin in an OVOL1-independent way, promoting barrier dysfunction [60], while it reduces the expression of skin barrier proteins and lipids by acting on keratinocytes, regulating the expression of metalloproteinase (MMP)-9 [61].”
BackgroundTurner, C. T., Zeglinski, M. R., Richardson, K. C., Santacruz, S., Hiroyasu, S., Wang, C., Zhao, H., Shen, Y., Sehmi, R., Lima, H., et al. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.05.095 · Cited by 58 · cited 1×
“Granzyme B, an apoptotic protease, also increases skin-barrier permeability through the fracturing of FLG and E-cadherin [64], while upregulated enolase-1 (ENO-1) leads to tight junction defects due to abnormal keratinization [65].”
BackgroundGonzalez, T., Stevens, M. L., Baatyrbek kyzy, A., Alarcon, R., He, H., Kroner, J. W., Spagna, D., Grashel, B., Sidler, E., Martin, L. J., et al. (2021) · Allergy · doi:10.1111/all.14489 · Cited by 58 · cited 1×
“Biofilm propensity by S. aureus and S. epidermidis has been positively associated with AD severity and epidermal dysfunction [86].”
BackgroundSchmid, B., Künstner, A., Fähnrich, A., Bersuch, E., Schmid‐Grendelmeier, P., Busch, H., Glatz, M., & Bosshard, P. P. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.18347 · Cited by 56 · cited 1×
“[ 89,90].”
Crisaborole Ointment 2%: A Review in Mild to Moderate Atopic Dermatitis
Hoy, S. M. (2017) · American Journal of Clinical Dermatology · doi:10.1007/s40257-017-0327-4 · Cited by 54 · cited 1×
“The PDE4 inhibitor, Crisabo-role is approved for topical treatment in patients older than two years old with mild to moderate diseases [40], while another promising selective PDE4 inhibitor, Difamilast (also OPA-15406 or MM36), has undergone phase II trials in pediatric and adult patients with…”
BackgroundPatella, V., Florio, G., Palmieri, M., Bousquet, J., Tonacci, A., Giuliano, A., & Gangemi, S. (2020) · Pediatric Allergy and Immunology · doi:10.1111/pai.13314 · Cited by 54 · cited 1×
“Exposure to increased levels of relative humidity means daily temperatures, precipitation, nitrogen dioxide (NO 2 ), ozone (O 3 ), particulate matter (PM10), and pollen counts are also positively associated with AD severity and exacerbation rates [114].”
BackgroundAtopic Dermatitis: Striving for Reliable Biomarkers
Mastraftsi, S., Vrioni, G., Bakakis, M., Nicolaidou, E., Rigopoulos, D., Stratigos, A., & Gregoriou, S. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11164639 · Cited by 54 · cited 2×
“Moreover, markers for predicting treatment response to specific therapies, such as serum periostin and dipeptidyl peptidase-4 (DPP-4) levels, have also been used to respond to anti-IL-13 treatment [ 153].”
BackgroundSelf-citationImmunopathology and Immunotherapy of Inflammatory Skin Diseases
Song, A., Lee, S. E., & Kim, J. H. (2022) · Immune Network · doi:10.4110/in.2022.22.e7 · Cited by 53
Moosbrugger‐Martinz, V., Hackl, H., Gruber, R. W., Pilecky, M., Knabl, L., Orth‐Höller, D., & Dubrac, S. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.05.102 · Cited by 52 · cited 1×
“Of note, colonization with fungi is site-dependent, i.e., Malassezia sp. being more abundant in the scapula; this phenomenon is potentially associated with variations in TEWL [92].”
BackgroundCapone, K. A., Kirchner, F., Klein, S., & Tierney, N. K. (2020) · Journal of Drugs in Dermatology · doi:10.36849/jdd.2020.4924 · Cited by 50 · cited 1×
“Emollient formulas of 1% colloidal oat or 5% Vitreoscilla filiformis lysate cream decrease the S. aureus population and increase skin microbial richness [96,97].”
BackgroundHirano, A., Goto, M., Mitsui, T., Hashimoto-Hachiya, A., Tsuji, G., & Furue, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091948 · Cited by 48
Lee, S.-J., Kim, S.-E., Shin, K.-O., Park, K., & Lee, S. E. (2021) · Allergy, Asthma & Immunology Research · doi:10.4168/aair.2021.13.5.762 · Cited by 47
Novel small molecule MRGPRX2 antagonists inhibit a murine model of allergic reaction
Kumar, M., Duraisamy, K., Annapureddy, R. R., Chan, C. B., & Chow, B. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.12.805 · Cited by 47
Silverberg, J. I., Lio, P., Simpson, E. L., Li, C., Brownell, D. R., Gryllos, I., Ng-Cashin, J., Krueger, T. S., Swaidan, V. R., Bliss, R., et al. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102002 · Cited by 43 · cited 1×
“Nitrosomonas eutropha , an ammonia-oxidizing bacteria, suppresses the T H 2-mediated response through the upregulation of IL-10 and reduction of S. aureus colonization [104]; the topical treatment is currently undergoing clinical trials for individuals with mild to moderate AD [104,105].”
BackgroundPark, S., Choi, H., & Bae, J.-H. (2016) · PubMed · doi:10.6133/apjcn.092015.23 · Cited by 40 · cited 1×
“Increased consumption of processed foods is correlated with AD severity, while low vitamin C and E intakes are inversely associated with AD [128,129].”
BackgroundSims, J. T., Chang, C.-Y., Higgs, R. E., Engle, S., Liu, Y., Sissons, S. E., Rodgers, G. H., Simpson, E. L., Silverberg, J. I., Forman, S. B., et al. (2021) · Experimental Dermatology · doi:10.1111/exd.14389 · Cited by 39 · cited 1×
“In adults with moderate to severe AD, two serum biomarkers-based clusters were identified: A low and a high inflammatory group, with the latter exhibiting a higher level of TNF β , monocyte chemoattractant protein 3 (MCP-)3/CCL7, and IL-13 [ 156].”
BackgroundAtopic dermatitis endotypes: knowledge for personalized medicine
Kim, J., & Ahn, K. (2022) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000820 · Cited by 37 · cited 1×
“The evolution of endotypes in AD and the ongoing research on the determination of non-invasive biomarkers have emerged as an important step toward targeted therapies for personalized treatment in AD patients [9].”
BackgroundHistamine Increases Th2 Cytokine-Induced CCL18 Expression in Human M2 Macrophages
Mommert, S., Schaper, J. T., Schaper‐Gerhardt, K., Gutzmer, R., & Werfel, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111648 · Cited by 35 · cited 2×
“More profoundly, IL-4 and IL-13, and to a lesser extent IL-10, upregulate CCL18 expression, while such an increase further stimulates H2R on IL-4 and IL-10-activated macrophages [47].”
BackgroundXie, B., & Li, X. (2018) · The Journal of Dermatology · doi:10.1111/1346-8138.14749 · Cited by 33 · cited 1×
“IL-4 has an additional role in AD pruritus by enhancing neural responsiveness to pruritogens [134], which by definition include biogenic amines, proteases, and neuropeptides, which in turn activate afferent dorsal ganglion neurons and receptors such as TRPV1 and TRPA1 [136].”
BackgroundIL‑18 knockout alleviates atopic dermatitis‑like skin lesions induced by MC903 in a mouse model
Chen, J., Niu, X., Gao, Y., Ma, L., Gao, X., Chen, H., & Qi, R. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4630 · Cited by 33
Atopic dermatitis across the life course
Abuabara, K., & Langan, S. (2022) · British Journal of Dermatology · doi:10.1093/bjd/ljac072 · Cited by 32 · cited 1×
“…lesions, consisting of papules and patches and the subsequent exudation and excoriation in the acute phase as well as the chronic lichenified, hy-perpigmented lesions are similar across all ages, although distinct clinical characteristics present across different age groups and ethnicities [2].”
BackgroundOpen trial of supplements of omega 3 and 6 fatty acids, vitamins and minerals in atopic dermatitis
Eriksen, B. B., & Dotterud, L. K. (2006) · Journal of Dermatological Treatment · doi:10.1080/09546630600621946 · Cited by 31 · cited 1×
“Meanwhile, the relationship between fatty acid intake and AD remains controversial [130,131].”
BackgroundLee, U. H., Kim, B. E., Kim, D. J., Cho, Y. G., Ye, Y. M., & Leung, D. Y. M. (2016) · British Journal of Dermatology · doi:10.1111/bjd.15010 · Cited by 31
Verzeaux, L., Vyumvuhore, R., Boudier, D., Guillou, M. L., Bordes, S., Essendoubi, M., Manfait, M., & Closs, B. (2017) · Experimental Dermatology · doi:10.1111/exd.13388 · Cited by 31 · cited 1×
“Moreover, alterations in lipid synthesis, lipid content, and structure reduction in AD patients further compromise skin integrity [ 50].”
BackgroundXu, Z., Liu, X., Niu, Y., Shen, C., Heminger, K., Moulton, L., Yu, A., Allen, T., Zhang, L. D., Yue, F., et al. (2019) · Australasian Journal of Dermatology · doi:10.1111/ajd.13153 · Cited by 31 · cited 1×
“The emollient application can ameliorate AD symptoms by decreasing S. aureus colonization and increasing microbial variety in the skin [95].”
BackgroundLee, Y. J., Yassa, C., Park, S.-H., Song, S. W., Jung, W. H., Lee, Y. W., Kang, H., & Kim, J. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076171 · Cited by 31 · cited 1×
“Ruxolitinib has been shown to reduce Malassezia in an in vitro skin model; however, data on the effect of JAK inhibitors in the microbiome of AD patients is limited [88].”
BackgroundDiosmin restores the skin barrier by targeting the aryl hydrocarbon receptor in atopic dermatitis
Lee, J., Song, K., & Jung, C. H. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153418 · Cited by 29 · cited 1×
“…to AHR and up-regulating the expression of barrier protein genes and skin integrity, such as tapinarof, a small molecule produced by bacteria, diosmin, a natural agonist derived from the Ruta-cae family, and other medical remedies, such as Rhodiola crenulate and Artemisia princeps [60,75–77].”
BackgroundHistamine Activates Human Eosinophils via H2R and H4R Predominantly in Atopic Dermatitis Patients
Beyer, L., Kabatas, A. S., Mommert, S., Stark, H., Werfel, T., Gutzmer, R., & Schaper‐Gerhardt, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810294 · Cited by 29 · cited 1×
“It has been shown that the IL-18 receptor (IL-18R α ) is also upregulated in the eosinophils of AD patients and that histamine enhances IL-18 expression in eosinophils through H 2 R and H 4 R, suggesting a key role for IL-18 and histamine in eosinophil-mediated inflammation in AD [44].”
BackgroundDietary habits in adult Japanese patients with atopic dermatitis
Ito, M., Morita, T., Okazaki, S., Koto, M., Ichikawa, Y., Takayama, R., Hoashi, T., Saeki, H., & Kanda, N. (2019) · The Journal of Dermatology · doi:10.1111/1346-8138.14881 · Cited by 28 · cited 1×
“Meanwhile, the relationship between fatty acid intake and AD remains controversial [130,131].”
BackgroundEvaluation of hand hygiene and onset of hand eczema after the outbreak of SARS-CoV-2 in Munich
Kendziora, B., Guertler, A., Ständer, L. M., Frey, S., French, L. E., Wollenberg, A., & Reinholz, M. (2020) · European Journal of Dermatology · doi:10.1684/ejd.2020.3923 · Cited by 28 · cited 1×
“Noteworthy, during the COVID-19 pandemic, the augmented use of disinfectants resulted in an increased number of AD cases and exacerbations [122].”
BackgroundLee, Y., Ryu, H. W., Yang, W., Park, M. H., Park, Y., Kim, D.-Y., Kwon, H. J., Kim, S.-Y., Oh, S., & Kim, S. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153407 · Cited by 27 · cited 1×
“Emerging therapeutic modalities aiming at epidermal barrier functionality restoration by decreasing epidermal hyperplasia, cytokine infiltration, and increasing skin-barrier protein production, such as spirodelapolyrhiza (SPE) and Olea europaea leaf extract (OLE), have been proposed [ 67].”
BackgroundMaura, D., Elmekki, N. M., & Goddard, C. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-93299-1 · Cited by 26 · cited 1×
“Nitrosomonas eutropha , an ammonia-oxidizing bacteria, suppresses the T H 2-mediated response through the upregulation of IL-10 and reduction of S. aureus colonization [104]; the topical treatment is currently undergoing clinical trials for individuals with mild to moderate AD [104,105].”
BackgroundEpidermal differentiation complex genetic variation in atopic dermatitis and peanut allergy
Huffaker, M. F., Kanchan, K., Bahnson, H. T., Ruczinski, I., Shankar, G., Leung, D. Y. M., Baloh, C., Toit, G. D., Lack, G., Nepom, G. T., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.11.008 · Cited by 26 · cited 1×
“…component, the lower expression of terminal differentiation markers, such as filaggrin (FLG) and loricrin (LOR), and the respective barrier permeability defect associated with the epithelial lipid film impairment and increased transepidermal water loss (TEWL) are well-established determinants [5].”
BackgroundYamada, K., Matsushita, K., Wang, J., & Kanekura, T. (2017) · Acta Dermato Venereologica · doi:10.2340/00015555-2807 · Cited by 25 · cited 1×
“Glucoseskin application in high concentrations can increase claudin-1 and FLG production [68], while Cimifugin, a bioactive Chinese herb, and the orally admin-istrated PAG (DL-propargylglycine) improve TJs function by suppressing allergic inflammation [69,70].”
BackgroundDouwes, J. E., Slater, T., Shanthakumar, M., McLean, D., Firestone, R. T., Judd, L., & Pearce, N. E. (2017) · International Journal of Occupational and Environmental Health · doi:10.1080/10773525.2018.1427307 · Cited by 24 · cited 1×
“It is well established that exposure to synthetic detergents is associated with an increased risk of work-related eczema, e.g., in professional cleaners, potentially through increased TEWL [121].”
BackgroundTohgasaki, T., Ozawa, N., Yoshino, T., Ishiwatari, S., Matsukuma, S., Yanagi, S., & Fukuda, H. (2018) · International Journal of Cosmetic Science · doi:10.1111/ics.12449 · Cited by 23 · cited 1×
“Granzyme B, an apoptotic protease, also increases skin-barrier permeability through the fracturing of FLG and E-cadherin [64], while upregulated enolase-1 (ENO-1) leads to tight junction defects due to abnormal keratinization [65].”
BackgroundNa, K., Lkhagva‐Yondon, E., Kim, M., Lim, Y., Shin, E., Lee, C., & Jeon, M. (2019) · Scandinavian Journal of Immunology · doi:10.1111/sji.12856 · Cited by 23 · cited 1×
“Glucoseskin application in high concentrations can increase claudin-1 and FLG production [68], while Cimifugin, a bioactive Chinese herb, and the orally admin-istrated PAG (DL-propargylglycine) improve TJs function by suppressing allergic inflammation [69,70].”
BackgroundSerum IL-21 levels are elevated in atopic dermatitis patients with acute skin lesions
Mizutani, H., Tamagawa‐Mineoka, R., Nakamura, N., Masuda, K., & Katoh, N. (2016) · Allergology International · doi:10.1016/j.alit.2016.10.010 · Cited by 22 · cited 1×
“Moreover, high serum IL-21 levels in AD patients, primarily produced by T H 17 cells, are associated with increased disease severity compared to healthy controls [35].”
BackgroundEmergency room visits for childhood atopic dermatitis are associated with floods?
Chen, N.-T., Chen, M.-J., Wu, C., & Guo, Y. L. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.145435 · Cited by 22 · cited 1×
“It is plausible that floods increase humidity, environmental dampness, allergen levels in the environment, in-door molds, and contaminated water, thereby contributing to AD exacerbation in sensitized children [113].”
BackgroundExpression of Helper and Regulatory T Cells in Atopic Dermatitis: A Meta-Analysis
Zhang, D.-J., Hao, F., Qian, T., & Cheng, H.-X. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.777992 · Cited by 22 · cited 1×
“Tregs usually suppress T2 expression; however, under presentation, the potential favoring of the T2-mediated immune response has been observed in AD patients compared to healthy controls [ 29,30].”
ResultVaněčková, J., & Bukač, J. (2016) · Food and Agricultural Immunology · doi:10.1080/09540105.2016.1183598 · Cited by 21 · cited 1×
“Finally, Ascomycota AD skin colonization is related to higher IgE titers and aggravation of AD severity [91].”
BackgroundSchaper‐Gerhardt, K., Köther, B., Wolff, L. J., Kabatas, A. S., Gehring, M., Nikolouli, E., Mommert, S., Werfel, T., & Gutzmer, R. (2020) · Allergy · doi:10.1111/all.14599 · Cited by 20
Nahm, D. (2023) · Life · doi:10.3390/life13081674 · Cited by 20 · cited 2×
“Notably, immunomodulatory strategies toward the activation of Tregs have been proposed, aiming at long-term remission of AD [30].”
BackgroundResultComparative Analysis of Cutaneous Fungi in Atopic Dermatitis Patients and Healthy Individuals
Choi, Y., Park, K. Y., Han, H. S., Lee, M., & Seo, S. J. (2022) · Annals of Dermatology · doi:10.5021/ad.2022.34.2.118 · Cited by 19 · cited 1×
“Specifically, in Candida sp. , C. albicans , and C. parapsilosis , colonization is increased in AD patients compared to healthy adults, while Malassezia species, especially M. restricta , M. globose , M. furfur , and M. sym-podialis , are frequently detected in AD lesions during disease flares [87].”
BackgroundThe Concept of One Health for Allergic Diseases and Asthma
Agache, I. O., Laculiceanu, A. G., Spanu, D. E., & Grigorescu, D. (2023) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2023.15.3.290 · Cited by 19 · cited 1×
“The recently introduced “meta-exposme” includes the complete set of environmental factors that impact halobionts, encompassing a holistic perspective of the policies and practices that shape the environment [109].”
BackgroundCzarnowicki, T., Kim, H. J., Villani, A. P., Glickman, J. W., DUCA, E. D., Han, J., Pavel, A. B., Lee, B. H., Rahman, A. H., Mérad, M., et al. (2021) · Allergy · doi:10.1111/all.14845 · Cited by 18 · cited 1×
“IL-21 has also been implicated in the pathogenesis of AD either by directly promoting the T2 pathway or suppressing the T H 1 immune response through INF-γ downregulation [36].”
BackgroundEngebretsen, K. A., Bandier, J., Kežić, S., Riethmüller, C., Heegaard, N. H. H., Carlsen, B. C., Linneberg, A. R., Johansen, J. D., & Thyssen, J. P. (2018) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14801 · Cited by 17
Galliano, M., Bäsler, K., Caruana, A., Mias, C., Bessou‐Touya, S., Brandner, J. M., & Duplan, H. (2020) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16516 · Cited by 17 · cited 1×
“In an ex vivo model, the microorganism component Aquaphilus dolo-miae induced immunomodulatory and antimicrobial peptides, thus, indirectly restoring skin barrier integrity when applied in cell cultures obtained from patients with AD [ 71].”
Hiroike, M., Sakabe, J., Kobayashi, M., Shimauchi, T., Ito, T., Hirakawa, S., Inoh, A., & Tokura, Y. (2013) · The Journal of Dermatology · doi:10.1111/1346-8138.12132 · Cited by 16 · cited 1×
“Such an effect depends on their size and shape, with acicular nanoparticles disrupting the epithelium skin barriers by altering cell junctions and the induction of inflammatory cytokines (IL-1 α , IL-1 β , IL-6, IL-8, and TNFa) [120].”
BackgroundImpact of sun exposure on adult patients affected by atopic dermatitis
Napolitano, M., Monfrecola, G., Fabbrocini, G., Fattore, D., Patrì, A., & Patruno, C. (2021) · Italian Journal of Dermatology and Venereology · doi:10.23736/s2784-8671.20.06582-7 · Cited by 16
Biomarkers in asthma in the context of atopic dermatitis in young children
Basu, M. N., Mortz, C. G., Jensen, T. K., Barington, T., Lambertsen, K. L., & Halken, S. (2022) · Pediatric Allergy and Immunology · doi:10.1111/pai.13823 · Cited by 16 · cited 1×
“C motif chemokine ligand 18 (CCL18), a chemokine strongly associated with increased morbidity in AD patients [46].”
BackgroundAnagawa-Nakamura, A., Ryoke, K., Yasui, Y., Shoda, T., & Sugai, S. (2020) · Toxicologic Pathology · doi:10.1177/0192623320970896 · Cited by 15 · cited 1×
“Delgocitinib, a JAK kinase inhibitor, in an ointment formulation, ameliorates TJ function without eliminating claudin expression [72], and bortezomib, a proteasome inhibitor, upregulates claudin-1 expression [73].”
BackgroundThe role of skin dysbiosis in atopic dermatitis
Braun, C., Patra, V., Lina, G., Nicolas, J., Vocanson, M., & Nosbaum, A. (2022) · European Journal of Dermatology · doi:10.1684/ejd.2022.4289 · Cited by 15 · cited 1×
“Thus, the skin in AD is prone to the penetration of exogenous agents, potentially facilitating a dysbiotic microbiome [6] and further contributing to keratinocyte damage and sustained skin inflammation [7].”
BackgroundHsa-mir-144-3p expression is increased in umbilical cord serum of infants with atopic dermatitis
Dissanayake, E., Inoue, Y., Ochiai, S., Eguchi, A., Nakano, T., Yamaide, F., Hasegawa, S., Kojima, H., Suzuki, H., Mori, C., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.09.024 · Cited by 14 · cited 1×
“Such reduction and compromised functionality of Tregs might also be attributed to exposure to tobacco smoke during pregnancy and microbiome dysbiosis [31,32].”
BackgroundKim, Y., Cho, N., Cheon, S., & Kim, K. K. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.08.120 · Cited by 13 · cited 1×
“Delgocitinib, a JAK kinase inhibitor, in an ointment formulation, ameliorates TJ function without eliminating claudin expression [72], and bortezomib, a proteasome inhibitor, upregulates claudin-1 expression [73].”
BackgroundPrevalence of adult self-reported atopic dermatitis in Greece: results from a nationwide survey
Stefanou, G., Gregoriou, S., Kontodimas, S., Sfaelos, K., Vakirlis, E., & Kourlaba, G. (2022) · European Journal of Dermatology · doi:10.1684/ejd.2022.4335 · Cited by 9 · cited 1×
“Even though AD is not associated with mortality and is therefore underreported compared to other fatal diseases, it imposes a significant morbidity burden due to the humanistic and psychosocial effects, both for patients and their families [3].”
BackgroundSelf-citationWinter, M., Thürmann, L., Gu, Z., Schüürmann, G., Herberth, G., Hinz, D., von Bergen�, M., Harms, H., Olek, S., Röder, S. W., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.01.034 · Cited by 7 · cited 1×
“Active or passive exposure to tobacco smoke is associated with an increased prevalence of AD in childhood by directly inhibiting Tregs function and impairing their ability to secrete the anti-inflammatory cytokine IL-10 following exposure to benzene [123].”
Background
Cited by
Update on the pathogenesis of atopic dermatitis.
Criado, P. R., Miot, H. A., Bueno-Filho, R., Ianhez, M., Criado, R. F. J., & de Castro, C. C. S. (2024) · Anais brasileiros de dermatologia · doi:10.1016/j.abd.2024.06.001 · Cited by 66
Interleukin-4 and Atopic Dermatitis: Why Does it Matter? A Narrative Review
Torres, T. R., Mendes‐Bastos, P., Cruz, M. J., Duarte, B., Filipe, P., Lopes, M. J. P., & Gonçalo, M. (2025) · Dermatology and Therapy · doi:10.1007/s13555-025-01352-y · Cited by 46
“This lipid deficiency further exacerbates barrier dysfunction and facil‑ itates the chronic inflammatory state observed in AD [42, 47].”
Advances in Atopic Dermatitis Treatment: From Pathogenesis to Natural Product‐Based Therapies
Fan, X., Liu, Z., Yang, W., Zhang, H., Zhong, H., Pang, Y., Ye, X., Wu, C., & Li, L. (2025) · Phytotherapy Research · doi:10.1002/ptr.70056 · Cited by 22
“The incidence rate of AD in infants is 11.3%–12.7% and 6.9%–7.6% in adults, respectively (Savva et al. 2024; Weins et al. 2024).”
InfluentialLivshits, G., & Kalinkovich, A. (2024) · Cells · doi:10.3390/cells13221899 · Cited by 16
Lin, Y., Zheng, L., Xu, Y., Wang, X., Li, J., Zheng, L., Liang, G., & Chen, L. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01322 · Cited by 16
Metadata
- Authors
- Savva, M., Papadopoulos, N. G., Gregoriou, S., Katsarou, S., Papapostolou, N., Makris, M., & Xepapadaki, P.
- Affiliations
- National and Kapodistrian University of Athens (GR)
- Department of Dermatology and Venereology, Faculty of Medicine, National and Kapodistrian University of Athens, Andreas Sygros Hospital, 16121 Athens, Greece
- Corresponding author
- Savva, Maria
- ORCID
- Venue
- Frontiers in Bioscience-Landmark
- Publisher
- IMR Press
- Published
- 2024-02-22
- Volume
- 29
- Issue
- 2
- Pages
- 84-84
- ISSN
- 2768-6698 (ISSN-L)
- 2768-6701
- OpenAlex
- W4392106846
- Semantic Scholar
- 4c9790a5cd6a4e9f456e1c65c61b1fe6d8ec96fb
- Cited by
- 53
- References
- 159
- Citations by year
- 2026: 18 · 2025: 26 · 2024: 9
- FWCI
- 4.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Frontiers in Bioscience-Landmark (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- atopic dermatitis, pathophysiology, skin barrier dysfunction, filaggrin, epidermal differentiation complex, genetic susceptibility, epigenetics, skin microbiome, exposome, dietary factors, IL-31, pruritus, endotypes, pediatric atopic dermatitis, quality of life, economic burden
- MeSH terms
- Adult, Child, Dermatitis, Atopic, Humans, Quality of Life, Skin, Cytokines, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.